Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II

Oncotarget. 2022 Jul 28:13:905-906. doi: 10.18632/oncotarget.28246. eCollection 2022.

Suparna Mazumder^{1

2

3}, Valerie Swank¹, Anton A Komar^{4

5}, Justin M Johnson^{1

4}, Vincent K Tuohy^{1

2

3

4}

¹ Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
² Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
³ Case Comprehensive Cancer Center, Cleveland, OH, USA.
⁴ Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, OH, USA.
⁵ Center for Gene Regulation in Health and Disease, Cleveland State University, Cleveland, OH, USA.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.27585.].